Find information on hypoparathyroidism diagnosis, including clinical documentation requirements, ICD-10 codes (E20.0), medical coding guidelines, and healthcare resources. Learn about calcium, parathyroid hormone (PTH) levels, symptoms, treatment, and management of hypoparathyroidism for accurate medical records and optimal patient care. This resource addresses common search queries related to hypocalcemia, tetany, neuromuscular irritability, and other relevant medical terms associated with hypoparathyroidism diagnosis and coding.
Also known as
Hypoparathyroidism
Deficient production of parathyroid hormone.
Pseudohypoparathyroidism
Resistance to parathyroid hormone effects.
Other specified disorders of parathyroid
Includes other parathyroid disorders not elsewhere classified.
Unspecified disorder of parathyroid
Parathyroid disorder not otherwise specified.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the hypoparathyroidism postsurgical?
Coding hypoparathyroidism as E89.0 (unspecified) when a more specific code (e.g., post-surgical) is applicable leads to inaccurate data and reimbursement.
Failing to code associated conditions like hypocalcemia (E83.5) or tetany (R29.0) with hypoparathyroidism undercodes severity and impacts quality metrics.
Miscoding pseudo-hypoparathyroidism (E83.3) as true hypoparathyroidism due to similar symptoms can lead to incorrect treatment plans and claims denials.
Patient presents with signs and symptoms suggestive of hypoparathyroidism. Presenting complaints may include muscle cramps, tetany, paresthesias, seizures, or fatigue. Physical examination may reveal Chvostek's sign or Trousseau's sign. Laboratory findings demonstrate hypocalcemia, hyperphosphatemia, and low parathyroid hormone (PTH) levels. Differential diagnosis includes pseudohypoparathyroidism, vitamin D deficiency, and renal failure. Diagnosis of hypoparathyroidism is confirmed based on clinical presentation, low PTH, and low calcium levels. Treatment plan includes calcium supplementation, vitamin D supplementation (ergocalciferol or cholecalciferol), and monitoring of serum calcium and phosphorus levels. Patient education provided regarding medication management, dietary adjustments, and the importance of regular follow-up appointments to monitor for potential complications such as nephrocalcinosis or cataracts. ICD-10 code E20.0 (hypoparathyroidism) is appropriate for this encounter. Patient's prognosis depends on adherence to treatment and management of potential long-term complications. Follow-up appointment scheduled to monitor response to therapy and adjust medications as needed.